These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 7838253

  • 1. Pathogenetic mechanisms involved in mesangial interposition in IgA nephropathy.
    Kubo S, Kim ST, Takasugi M, Kuroiwa A.
    Nephron; 1994; 68(3):308-13. PubMed ID: 7838253
    [Abstract] [Full Text] [Related]

  • 2. Mesangial factor V expression colocalized with fibrin deposition in IgA nephropathy.
    Liu N, Ono T, Suyama K, Nogaki F, Shirakawa K, Maeda M, Kawamura T, Kamata T, Oyama A, Muso E, Sasayama S.
    Kidney Int; 2000 Aug; 58(2):598-606. PubMed ID: 10916083
    [Abstract] [Full Text] [Related]

  • 3. [Study on platelet-derived growth factor (PDGF) and PDGF receptor expression in glomeruli and corticosteroid therapy in IgA nephropathy].
    Naito T.
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1113-22. PubMed ID: 7815743
    [Abstract] [Full Text] [Related]

  • 4. Platelet-derived growth factor mesangial deposits in mesangial IgA glomerulonephritis.
    Nakajima M, Hewitson TD, Mathews DC, Kincaid-Smith P.
    Nephrol Dial Transplant; 1991 Oct; 6(1):11-6. PubMed ID: 2057110
    [Abstract] [Full Text] [Related]

  • 5. [Immunoelectron microscopic studies of IgA nephropathy in children].
    Tanaka M.
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):83-93. PubMed ID: 3699683
    [Abstract] [Full Text] [Related]

  • 6. Ultrastructure of mesangial type III collagen deposition in a patient with IgA nephropathy.
    Kunitomi M, Wada J, Miyatake N, Hayashi Y, Ota K, Makino H.
    Am J Kidney Dis; 1998 Jul; 32(1):146-52. PubMed ID: 9669436
    [Abstract] [Full Text] [Related]

  • 7. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
    Rong ZH, Wang C, Hao J, Duan HJ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):275-8. PubMed ID: 18471357
    [Abstract] [Full Text] [Related]

  • 8. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis.
    Gesualdo L, Pinzani M, Floriano JJ, Hassan MO, Nagy NU, Schena FP, Emancipator SN, Abboud HE.
    Lab Invest; 1991 Aug; 65(2):160-7. PubMed ID: 1715446
    [Abstract] [Full Text] [Related]

  • 9. [Distribution of fibronectin in kidney of IgA nephropathy and its clinicopathological correlation].
    Shi Y, Li L, Zhou H.
    Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):390-3. PubMed ID: 10374298
    [Abstract] [Full Text] [Related]

  • 10. [Clinicopathologic features of membranous nephropathy coexisting with IgA nephropathy].
    Wang SX, Zou WZ, Yang L, Zhao MH.
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):171-4. PubMed ID: 17535683
    [Abstract] [Full Text] [Related]

  • 11. [An electron microscopic study of circumferential mesangial interposition in various renal diseases].
    Maruyama Y.
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):263-75. PubMed ID: 9654910
    [Abstract] [Full Text] [Related]

  • 12. Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?
    Westhoff TH, Waldherr R, Loddenkemper C, Ries W, Zidek W, van der Giet M.
    Clin Nephrol; 2006 Mar; 65(3):203-7. PubMed ID: 16550751
    [Abstract] [Full Text] [Related]

  • 13. [IgA nephropathy--analysis of 60 cases].
    Danilewicz M, Wagrowska-Danilewicz M.
    Pol Tyg Lek; 2006 Mar; 49(6-7):141-3. PubMed ID: 8090667
    [Abstract] [Full Text] [Related]

  • 14. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P.
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [Abstract] [Full Text] [Related]

  • 15. [Studies on the intraglomerular distribution of fibronectin in IgA nephropathy--in relation to clinical pictures and prognosis].
    Urae M.
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):389-99. PubMed ID: 2198363
    [Abstract] [Full Text] [Related]

  • 16. Tubulointerstitial lesions in IgA nephropathy and localization of hepatocyte growth factor.
    Fidirkin A, Niemark A, Nepomnyashchikh D, Olovyannikov S, Tanashkin S, Sapoznikova L.
    Int Urol Nephrol; 1999 Apr; 31(4):557-62. PubMed ID: 10668952
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical studies of extracellular matrix components and integrins in IgA nephropathy.
    Kanahara K, Yorioka N, Arita M, Ohira N, Yamakido M.
    Nephron; 1994 Apr; 66(1):29-37. PubMed ID: 7509047
    [Abstract] [Full Text] [Related]

  • 18. Computer imaging analysis of glomerular extracellular components in patients with IgA nephropathy.
    Tomino Y, Funabiki K, Shirato I, Koide H, Eguchi K, Yagame M, Sakai H.
    Acta Pathol Jpn; 1989 May; 39(5):296-305. PubMed ID: 2692398
    [Abstract] [Full Text] [Related]

  • 19. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM.
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [Abstract] [Full Text] [Related]

  • 20. Mesangial expression of a nonmuscle myosin heavy chain, SMemb, is associated with glomerular sclerosis and renal prognosis in IgA nephropathy.
    Mise N, Kimura K, Nagai R, Ohba S, Suzuki N, Miyashita K, Tojo A, Goto A, Omata M.
    Nephron; 1998 Oct; 78(3):284-9. PubMed ID: 9546688
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.